(Q78402068)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390307%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390307%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390307%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

C Thivolet

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390307%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390307%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390307%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390307%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390307%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

204-211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390307%20AND%20SRC:MED&resulttype=core&format=json

Insulin-dependent diabetes mellitus as an autoimmune disease

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Insulin-dependent diabetes mellitus: the initial lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

A defect in central tolerance in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Breaking self-tolerance in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

The role of nasopharyngeal lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Effect of oral and intravenous insulin and glutamic acid decarboxylase in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Inhibition of T-cell responsiveness by nasal peptide administration: influence of the thymus and differential recovery of T-cell-dependent functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Kinetics of peptide uptake and tissue distribution following a single intranasal dose of peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Decrease of LFA-1 is associated with upregulation of TGF-beta in CD4(+) T cell clones derived from rats nasally tolerized against experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Transplanted MHC class I-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Total dose and frequency of administration critically affect success of nasal mucosal tolerance induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Mucosal Antigen Primes Diabetogenic Cytotoxic T-Lymphocytes Regardless of Dose or Delivery Route

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01988.X

Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue

21 January 2018

1 reference

12 December 2020

Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells

1 reference

12 December 2020

Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis

1 reference

12 December 2020

Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4

1 reference

12 December 2020

Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice

1 reference

12 December 2020

The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression

1 reference

12 December 2020

10.1046/J.1365-2249.2002.01988.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390307%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference